Person profile

Public information reviewed

Gerald T. Proehl

Role

PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (NASDAQ: DRMA)

Board role

Director · TENAX THERAPEUTICS, INC. (NASDAQ: TENX)

Board role

Director · Dermata Therapeutics, Inc. (NASDAQ: DRMA)

TENAX THERAPEUTICS, INC. (NASDAQ: TENX)

Director · Current mandate

Director · Executive
FollowSave PDF
More
Reports & analysis (Check report directory)Alpha Eval
Evidence records
7
Profile ownership
Not yet claimed
Record reviewed
May 16, 2026
View evidence

Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Experienced pharmaceutical executive with strong background in business operations and commercial strategy. Co-founded Santarus, Inc. and served as President and CEO until its sale to Salix Pharmaceuticals for $2.6 billion. Currently Founder, President, CEO and Chair of Dermata Therapeutics, Inc.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

TENAX THERAPEUTICS, INC.

2014-01-01 · current

Confirmed by public sourceView source

Director

Dermata Therapeutics, Inc.

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Dermata Therapeutics, Inc.

Open Dermata Therapeutics, Inc. profile →

Director at Dermata Therapeutics, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

Dermata Therapeuti…Dermata Therapeutics, Inc.TENAX THERAPEUTICS…TENAX THERAPEUTICS, INC.Gerald T. Proehl

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Form OwnershipPublic profile sourceSupports Director at Dermata Therapeutics, Inc. (NASDAQ: DRMA), PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (NASDAQ: DRMA), Executive title.Open sourceSource 2 · Sec FilingTENX DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 3 · Sec FilingDRMA DEF 14A director slateSupports Board role, Committee assignments.Open sourceSource 4 · Sec FilingDRMA 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:gerald-t-proehl
Record version
public-0

Published evidence records

7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec form ownership · Source published: Aug 16, 2026 · Retrieved: Sep 12, 2026

    Supports 3 claims
    • Professional Role: Director at Dermata Therapeutics, Inc. · Claim reviewed: May 16, 2026
    • Professional Role: PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: PRESIDENT, CHAIRMAN, CEO · Claim reviewed: May 16, 2026

  2. TENX DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Chair · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Compensation, Corporate Governance and Nominating · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Dermata Therapeutics, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Founder, President, Chief Executive Officer and Chair · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  3. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 25, 2026

    Supports 1 claim
    • Professional Role: Director at TENAX THERAPEUTICS, INC. · Claim reviewed: May 16, 2026

  4. DRMA DEF 14A director slate

    sec filing · Source published: Apr 17, 2026 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Chair · Claim reviewed: May 16, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026

  5. DRMA 10-K executive officers

    sec filing · Source published: Mar 26, 2026 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Dermata Therapeutics, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President, Chief Executive Officer and Chairman · Claim reviewed: May 16, 2026
    • Other Company Role: Gerald T. Proehl is also linked to Tenax Therapeutics, Inc. as Chairman of the Board. · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of TENAX THERAPEUTICS, INC. · Claim reviewed: May 16, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Dermata Therapeutics, Inc. · Claim reviewed: May 16, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of Dermata Therapeutics, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of TENAX THERAPEUTICS, INC.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · CorroboratedBoard role: ChairSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Compensation, Corporate Governance and Nominating1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · CorroboratedExecutive at Dermata Therapeutics, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Founder, President, Chief Executive Officer and Chair1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: PRESIDENT, CHAIRMAN, CEO1 source
Verification
Source reported
Confidence
100%
Last reviewed
May 16, 2026
Executive title · Source reportedExecutive title: President, Chief Executive Officer and Chairman1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedGerald T. Proehl is also linked to Tenax Therapeutics, Inc. as Chairman of the Board.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources7 records
  1. https://www.sec.gov/Archives/edgar/data/1853816/000149315226039048/ownership.xml

    Sec Form Ownership · Tier not stated · Reviewed Sep 12, 2026

    Supports: Director at Dermata Therapeutics, Inc. (NASDAQ: DRMA) · PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (NASDAQ: DRMA) · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  3. https://www.sec.gov/Archives/edgar/data/34956/000119312526168580/tennx-20260417.htm

    Sec Proxy · Tier not stated · Reviewed Apr 25, 2026

    Supports: Director at TENAX THERAPEUTICS, INC. (NASDAQ: TENX)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background

  6. https://www.sec.gov/Archives/edgar/data/34956/000119312526168580/tennx-20260417.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  7. https://www.sec.gov/Archives/edgar/data/1853816/000149315226039048/ownership.xml

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership